PFAS survey delays have left wastewater utilities, industrial dischargers, and regulators working with an incomplete federal evidence base for influent, effluent, biosolids, and industrial source identification. As of September 29, 2026, the central issue is not whether PFAS in wastewater is a policy concern; the record described by EPA and state agencies shows active concern. The more difficult question is how far regulators can move toward enforceable wastewater controls while the national data collection remains pending.

EPA submitted its Information Collection Request for the POTW Influent PFAS Study to the White House Office of Management and Budget in October 2024, and the research record states that the request remained unapproved as of September 2026. EPA describes the study as a planned survey of about 400 publicly owned treatment works, focused on larger facilities and those serving at least 50,000 people, with sampling intended to examine PFAS and adsorbable organic fluorine in influent, effluent, and industrial discharges through EPA Method 1633 and Method 1621 EPA POTW study.

Why PFAS survey delays Matter For Wastewater Rules

Regulatory Timing Is Now A Data Problem

The Clean Water Act framework depends heavily on defensible information about sources, treatability, discharge pathways, and sector-level variation. For PFAS, that creates a difficult timing problem. Federal regulators can see enough risk signals to justify concern, but a delayed national survey limits the ability to compare facilities, industrial categories, influent concentrations, effluent outcomes, and biosolids data under a common study design.

The practical result of PFAS survey delays is uncertainty rather than inaction alone. Utilities still receive industrial wastewater. Industrial users still need to evaluate whether supplied mixtures, coatings, surfactants, processing aids, or impurities may contribute PFAS to wastewater. State agencies continue to ask questions about biosolids management. Yet the national dataset intended to support more targeted federal regulation has not been completed.

PFAS survey delays And Legal Defensibility

Effluent limitation guidelines, pretreatment requirements, and permit conditions are more defensible when they are built on standardized data rather than isolated samples. A national survey can help distinguish high-contribution sectors from lower-contribution ones, identify recurring industrial source categories, and support decisions about where control technology review should begin. Without that dataset, rulemaking may become slower, more cautious, or more vulnerable to disputes over representativeness.

This does not mean federal agencies lack authority to act. It means that any action taken before completion of the survey may need to rely on a narrower factual record. For regulated facilities, that gap matters because compliance planning depends on knowing whether future controls will apply broadly to municipal treatment works, directly to industrial users, or through pretreatment programs and permit conditions.

What The Federal Study Would Measure

Survey Scope And Methods

The planned POTW study is significant because it is designed to examine multiple wastewater points rather than only final discharge. Sampling influent can show what enters the treatment works. Effluent data can indicate what leaves after treatment. Industrial discharge data can help identify which upstream sources may be contributing. Biosolids sampling can show how PFAS may partition into sewage sludge rather than remaining only in water.

The linked national sewage sludge survey is designed to measure 40 PFAS analytes in sewage sludge. According to the research record, EPA intends those data to support future risk assessment and potential regulation. That distinction is important: the survey itself is not a discharge limit, a biosolids ban, or a permit condition. It is an evidence-gathering tool that may later support such decisions.

Industrial Discharge Evidence Gap

For industrial facilities, the absence of completed federal survey results shifts attention to internal documentation. A plant may not intentionally manufacture PFAS, yet PFAS can still enter through supplied materials or process chemistry. Supplier declarations, safety data sheets, wastewater characterization, and purchasing records become part of the compliance file even before a final federal wastewater rule is issued.

That evidence gap is already visible in compliance planning. Facilities may need to document assumptions about whether PFAS are present, which operations could send them to drains, and which suppliers can confirm composition information. More information on how discharge and biosolids questions can become documentation issues is discussed in another article about PFAS wastewater survey delays. Industrial buyers comparing chemical-supply documentation practices can also review related material at Mengo Industries, a related site in the same network.

Biosolids Risk Signals And State Action

Draft Federal Risk Findings Remain Limited

EPA’s January 14, 2025 draft risk assessment for PFOA and PFOS in biosolids, as described in the research record, found that human health risks may exceed EPA’s acceptable thresholds under typical exposure scenarios for common sludge disposal or use methods, including land application, landfill, and incineration, even around 1 part per billion. That finding is not the same as a final national biosolids rule, but it indicates why wastewater and sludge data are central to the regulatory discussion.

The same draft assessment also had stated limits. It did not include high-end exposure rates, exposure from sources other than biosolids, combined effects of PFOA, PFOS, and precursors, or non-typical biosolids application practices. Those exclusions do not make the risk signal irrelevant. They mean the assessment should be read as a draft federal analysis with defined assumptions, not a complete account of all exposure pathways.

State Testing Shows Why Waiting Is Difficult

States have not waited for the federal survey to answer every question. Washington State reported that in 2024 it partnered with 44 wastewater treatment plants for voluntary PFAS testing in biosolids and found PFAS in almost every sample, regardless of plant size or location Washington biosolids information. That finding does not provide a national estimate by itself, but it shows why biosolids managers face immediate questions about sampling, land application, public communication, and disposal choices.

For municipal utilities, biosolids management is not a side issue. Treatment plants may not be the original source of PFAS, yet they can concentrate or move PFAS through sludge handling routes. That creates a regulatory tension: utilities can be asked to manage contamination they did not create, while industrial users may be asked to provide better source information before national standards are finalized.

Compliance Planning While Federal Data Remain Pending

What Wastewater Facilities Can Document Now

Wastewater facilities cannot complete the federal survey on their own, but they can reduce uncertainty in their own records. The most defensible approach is to separate confirmed data from assumptions. That means identifying whether PFAS sampling has been performed, which methods were used, which industrial users may be relevant, and whether biosolids have been tested under a documented protocol.

• Track industrial contributors by process type, not only by customer name.
• Record whether PFAS information comes from sampling, supplier declarations, permit files, or inference.
• Keep biosolids decisions linked to test results, disposal route, and state guidance in effect on the decision date.
• Document data gaps rather than treating missing supplier information as proof of absence.

This approach does not guarantee future compliance. It does, however, create a clearer record for permit discussions, pretreatment reviews, public inquiries, and budget requests. For industrial dischargers, it also makes supplier follow-up more specific because the question becomes tied to a wastewater pathway rather than a broad request for all PFAS-related information.

Budgeting And Technology Decisions Need Assumptions

PFAS treatment can involve significant technical and cost questions, but the research record provided here does not establish a single preferred technology, cost curve, or removal rate for all wastewater plants. That uncertainty should be reflected in capital planning. Facilities should avoid treating a preliminary vendor estimate, pilot study, or single sampling result as a complete compliance forecast.

Instead, planning documents can identify decision triggers: federal approval of the survey, release of survey results, proposed effluent guidelines, state biosolids restrictions, permit reopening, or new industrial user data. That form of planning is cautious, but it is more useful than assuming the eventual federal rule will either be minimal or universally strict.

PFAS survey delays Require Documented Assumptions

PFAS survey delays do not remove compliance pressure. They redistribute it. EPA still has stated data needs, state agencies are collecting information where they can, and wastewater utilities must respond to biosolids and discharge questions with the evidence available to them on the decision date.

The near-term task for wastewater plants and industrial users is therefore evidence management. Facilities should identify what is known, what is assumed, what remains untested, and which suppliers or discharge points require follow-up. That record will not replace national survey data, but it can reduce avoidable uncertainty while federal wastewater PFAS policy continues to develop from an incomplete dataset.